Less Ads, More Data, More Tools Register for FREE

Pin to quick picksClean Power Hyd Regulatory News (CPH2)

  • This share is currently suspended. It was suspended at a price of 13.60

Share Price Information for Clean Power Hyd (CPH2)

Share Price is delayed by 15 minutes
Get Live Data
13.60    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.00 (0.00%)
Market Cap: £68.27m
CPH2 Live PriceLast checked at - London Stock Exchange

Intraday Clean Power Hyd Share Chart

PDMR Dealing

21 Feb 2022 16:21

RNS Number : 3309C
Clean Power Hydrogen
21 February 2022
 

21 February 2022

Clean Power Hydrogen plc

("CPH2", the "Company" or the "Group)

PDMR Dealing

Clean Power Hydrogen plc (AIM: CPH2), the UK-based green hydrogen technology and manufacturing group that has developed the IP-protected Membrane-Free Electrolyser, was informed on 21 February 2022 of the following transactions in the Company's ordinary shares by a PDMR.

The information in the below notification is disclosed in accordance with Article 19 of the EU Market Abuse Regulation.

1

 

Details of the person discharging managerial responsibilities ("PDMR") / person closely associated ("PCA")

a)

Name

 Henry Price

2

Reason for the notification

a)

Position/status

PDMR - Non-Executive Director Clean Power Hydrogen Group Limited

b)

Initial notification /Amendment

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Clean Power Hydrogen plc

b)

LEI

9845009D2AB08E5BF491

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

Ordinary shares of £0.01 each

Identification code

GB00BP371R64

b)

Nature of the transaction

Purchase of Ordinary Shares

c)

 

Price(s) and volume(s)

 Date

Price(s)

Volume(s)

16 February 2022

£0.6275

6,303

d)

 

Aggregated information

- Aggregated volume

6,303 ordinary shares

- Price

£3,955.13

e)

Date of the transaction

16 February 2022

f)

Place of the transaction

London Stock Exchange (AIM: CPH2)

 

For more information, please contact:

Clean Power Hydrogen Plc

via Camarco

Jon Duffy, Chief Executive Officer

Cenkos Securities plc - NOMAD & Broker

Neil McDonald

+44 (0)131 220 9771

Peter Lynch

+44 (0)131 220 9772

Adam Rae

+44 (0)131 220 9778

Camarco PR

+ 44(0) 203 757 4980

Owen Roberts

Monique Perks

Billy Clegg

 

Notes to Editors

 

Clean Power Hydrogen plc ("CPH2") is a rapidly-growing UK-based green hydrogen technology and manufacturing group. The Group designs and manufactures hydrogen production units and is focused on the commercial production of green hydrogen in a simple, safe, and sustainable manner

 

CPH2 has advanced the development of hydrogen as a green energy by demonstrating a new form of production. CPH2 has developed unique, IP-protected Membrane-Free Electrolyser™ ("MFE") technology - an efficient, cost-effective and reliable means of producing hydrogen - which is disrupting the traditional electrolyser market and accelerating the progress towards a zero-carbon future.

 

CPH2 is listed on the AIM market of the London Stock Exchange ("LSE") (AIM: CPH2) and was awarded the Green Economy Mark by the LSE, which recognises listed companies that derive more than 50% of their revenues from the green economy.

 

Cenkos Securities plc, which is authorised and regulated by the Financial Conduct Authority in the UK, is acting exclusively for the Group and no one else in connection with Admission. Cenkos Securities plc will not regard any other person as its client in relation to Admission and will not be responsible to anyone other than the Group for providing the protections afforded to its clients, nor for providing advice in relation to the contents of this announcement or any transaction, arrangement or other matter referred to herein.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHBKDBDABKDCBB
Date   Source Headline
12th Dec 20225:14 pmRNSInvestment in ATOME Energy plc
6th Dec 20227:00 amRNSSenior Management Team Strengthened
22nd Nov 202211:06 amRNSSecond Price Monitoring Extn
22nd Nov 202211:00 amRNSPrice Monitoring Extension
22nd Nov 20229:00 amRNSPrice Monitoring Extension
22nd Nov 20227:00 amRNSOperational Update
4th Oct 20224:41 pmRNSSecond Price Monitoring Extn
4th Oct 20224:35 pmRNSPrice Monitoring Extension
23rd Sep 20227:00 amRNSInterim results
23rd Sep 20227:00 amRNSInterim results
7th Sep 20224:45 pmRNSHolding(s) in Company
5th Sep 20227:00 amRNSAppointment of James Hobson as CFO
5th Sep 20227:00 amRNSAgreement with KCA Deutag Group
24th Aug 20228:11 amRNSOperational Update
19th Jul 20225:55 pmRNSResult of AGM
19th Jul 20227:45 amRNSLicence Agreement with GHFG Ltd.
23rd Jun 20225:24 pmRNSNotice of 2022 Annual General Meeting
27th May 20227:00 amRNSGroup Annual Report and Financial Statements
29th Apr 202210:16 amRNSOperations Update
4th Apr 202212:15 pmRNSAdditional purchase order from existing customer
21st Mar 20227:00 amRNSNew purchase order from additional customer
21st Mar 20227:00 amRNSOperations Update
2nd Mar 20225:31 pmRNSHolding(s) in Company
1st Mar 20224:41 pmRNSSecond Price Monitoring Extn
1st Mar 20224:36 pmRNSPrice Monitoring Extension
1st Mar 202211:49 amRNSHolding(s) in Company
21st Feb 20224:21 pmRNSPDMR Dealing
16th Feb 20227:00 amRNSAdmission to AIM and First Day of Dealings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.